Literature DB >> 25815254

Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Stefano Pallanti1, Luana Salerno1.   

Abstract

Schizophrenia and attention deficit hyperactivity disorder (ADHD) are two psychiatric disorders with a negative impact on quality of life of individuals affected. Although they are classified into distinct disorders categories, attentional dysfunction is considered as a core feature in both conditions, either at the clinical then pathophysiological level. Beyond the obvious clinical overlap between these disorders, the Research Domain Criteria approach might offer an interesting perspective for disentangling common circuits underpinning both disorders. Hence, we review evidences regarding the overlap between schizophrenia and ADHD, at the clinical level, and at the level of underlying brain mechanisms. The evidence regarding the influence of environmental risk factors in the emergence of both disorders, and their developmental trajectories is also reviewed. Among these, we will try to elucidate the complex relationship between stimulants use and psychotic symptoms, discussing the potential role of ADHD medication in inducing psychosis or in exacerbating it. We aim that, taken together, these findings may promote further investigation with important implications both for clinicians and research. In fact, considering the amounting evidence on the overlap between schizophrenia and ADHD, the delineation of their boundaries might help in the decision for diagnosis and treatment. Moreover, it may help to promote interventions focused on the prevention of both schizophrenia and ADHD, by the reduction of recognized environmental risk factors.

Entities:  

Keywords:  Attention deficit disorder with hyperactivity; Central nervous system stimulants; Psychotic disorders; Schizophrenia; Toxic psychoses

Year:  2015        PMID: 25815254      PMCID: PMC4369549          DOI: 10.5498/wjp.v5.i1.47

Source DB:  PubMed          Journal:  World J Psychiatry        ISSN: 2220-3206


  116 in total

Review 1.  Epigenetics and the environmental regulation of the genome and its function.

Authors:  Tie-Yuan Zhang; Michael J Meaney
Journal:  Annu Rev Psychol       Date:  2010       Impact factor: 24.137

Review 2.  Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Authors:  Markus Kraemer; Jennifer Uekermann; Jens Wiltfang; Bernhard Kis
Journal:  Clin Neuropharmacol       Date:  2010-07       Impact factor: 1.592

3.  Birth weight, schizophrenia, and adult mental disorder: is risk confined to the smallest babies?

Authors:  Kathryn M Abel; Susanne Wicks; Ezra S Susser; Christina Dalman; Marianne G Pedersen; Preben Bo Mortensen; Roger T Webb
Journal:  Arch Gen Psychiatry       Date:  2010-09

4.  Serum ferritin in children with attention-deficit hyperactivity disorder.

Authors:  J Gordon Millichap; Michelle M Yee; Sonia I Davidson
Journal:  Pediatr Neurol       Date:  2006-03       Impact factor: 3.372

5.  Looking for childhood-onset schizophrenia: the first 71 cases screened.

Authors:  K McKenna; C T Gordon; M Lenane; D Kaysen; K Fahey; J L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-06       Impact factor: 8.829

6.  Inhibition in children with attention-deficit/hyperactivity disorder: a psychophysiological study of the stop task.

Authors:  Carin C E Overtoom; J Leon Kenemans; Marinus N Verbaten; Chantal Kemner; Maurits W van der Molen; Herman van Engeland; Jan K Buitelaar; Harry S Koelega
Journal:  Biol Psychiatry       Date:  2002-04-15       Impact factor: 13.382

7.  P50 sensory gating in panic disorder.

Authors:  Eduardo S Ghisolfi; Elizeth Heldt; Ana Paula Zanardo; Ivo M Strimitzer; Alexandre S Prokopiuk; Jefferson Becker; Aristides V Cordioli; Gisele G Manfro; Diogo R Lara
Journal:  J Psychiatr Res       Date:  2006-04-17       Impact factor: 4.791

Review 8.  Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.

Authors:  Karen Markussen Linnet; Søren Dalsgaard; Carsten Obel; Kirsten Wisborg; Tine Brink Henriksen; Alina Rodriguez; Arto Kotimaa; Irma Moilanen; Per Hove Thomsen; Jørn Olsen; Marjo-Riitta Jarvelin
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

9.  Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence.

Authors:  Eduardo S Ghisolfi; Regina Margis; Jefferson Becker; Ana Paula Zanardo; Ivo M Strimitzer; Diogo R Lara
Journal:  Int J Psychophysiol       Date:  2004-02       Impact factor: 2.997

10.  Visual perception and its impairment in schizophrenia.

Authors:  Pamela D Butler; Steven M Silverstein; Steven C Dakin
Journal:  Biol Psychiatry       Date:  2008-07-01       Impact factor: 13.382

View more
  7 in total

1.  Managing the comorbidity of schizophrenia and ADHD.

Authors:  Amy Gough; Jason Morrison
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

2.  Effectiveness of Prescription-Based CNS Stimulants on Hospitalization in Patients With Schizophrenia: A Nation-Wide Register Study.

Authors:  Christopher Rohde; Christoffer Polcwiartek; Marton Asztalos; Jimmi Nielsen
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

3.  Symptom Overlap and Screening for Symptoms of Attention-Deficit/Hyperactivity Disorder and Psychosis Risk in Help-Seeking Psychiatric Patients.

Authors:  Salvatore Corbisiero; Anita Riecher-Rössler; Jacqueline Buchli-Kammermann; Rolf-Dieter Stieglitz
Journal:  Front Psychiatry       Date:  2017-10-30       Impact factor: 4.157

4.  Delusion-proneness displays comorbidity with traits of autistic-spectrum disorders and ADHD.

Authors:  Anaïs Louzolo; Petter Gustavsson; Lars Tigerström; Martin Ingvar; Andreas Olsson; Predrag Petrovic
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

5.  Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex.

Authors:  Esther Castillo-Gómez; Marta Pérez-Rando; María Bellés; Javier Gilabert-Juan; José Vicente Llorens; Héctor Carceller; Clara Bueno-Fernández; Clara García-Mompó; Beatriz Ripoll-Martínez; Yasmina Curto; Noelia Sebastiá-Ortega; María Dolores Moltó; Julio Sanjuan; Juan Nacher
Journal:  eNeuro       Date:  2017-05-01

6.  Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.

Authors:  Maria Niarchou; Samuel J R A Chawner; Ania Fiksinski; Jacob A S Vorstman; Johanna Maeder; Maude Schneider; Stephan Eliez; Marco Armando; Maria Pontillo; Stefano Vicari; Donna M McDonald-McGinn; Beverly S Emanuel; Elaine H Zackai; Carrie E Bearden; Vandana Shashi; Stephen R Hooper; Michael J Owen; Raquel E Gur; Naomi R Wray; Marianne B M van den Bree; Anita Thapar
Journal:  Schizophr Res       Date:  2018-08-07       Impact factor: 4.939

7.  Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia.

Authors:  I Arican; N Bass; K Neelam; K Wolfe; A McQuillin; G Giaroli
Journal:  Acta Psychiatr Scand       Date:  2018-08-13       Impact factor: 6.392

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.